Office-based treatment for opioid addiction achieving goals

Article Abstract:

Office-based buprenorphine treatment represents a new paradigm for treating opioid addiction and officials believe that making buprenorphine available through qualified primary care physicians and addiction specialists would attract a new group of patients. The Substance Abuse and Mental Health Services Administration provides educational materials on its Web sites and offers an online mentoring program for clinicians.

Management dynamics, Care and treatment, Management, Substance abuse, Dosage and administration, Drug use, Company business management, Buprenorphine, United States. Substance Abuse and Mental Health Services Administration

---

Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin

Article Abstract:

The efficacy and safety of opioid agonists for the treatment of neuropathic pain is assessed with reference to published randomized controlled trials (RCTs). While short-term studies provide only equivocal evidence regarding the efficacy of opioids in reducing the intensity of neuropathic pain, further RCTs are needed to establish their long-term efficacy, safety, and effects on quality of life.

Methods, Usage, Clinical trials, Pain, Pain management

---

A 35-year-old physician with opioid dependence

Article Abstract:

Details about a substance dependence problem faced by a specialist physician who became addicted to hydrocodone, are presented. Various recommendations and alternatives to come out of such addiction are mentioned.

Science & research, Research, Case studies, Drug abuse, Hydrocodone

Similar abstracts:

• Abstracts: A controlled trial of buprenorphine treatment for opioid dependence. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
• Abstracts: Case-finding instruments for depression in primary care settings
• Abstracts: Airline travel and infection. The evolving technology of venous access. The antibiotic pipeline - challenges, costs, and values
• Abstracts: A black-box warning for antidepressants in children? Today's FDA. Beyond fast track for drug approvals
• Abstracts: Anatomical redesign for the treatment of dens invaginatus type III with open apexes. Removal of oral biofilms by bubbles

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.